Side Effect Management | News

Patients Who Experienced Chemotherapy-Induced Nausea/Vomiting During First Cycle of Cancer Treatment May Be at Greater Risk for Recurrence of the Side Effect

December 12th 2020

By Brielle Benyon

Approximately half of the patients with breast cancer who failed anti-nausea or vomiting therapy for chemotherapy-induced nausea/vomiting during their first cycle of treatment failed to avoid the side effect at some point during the next three treatment cycles.

FDA Authorizes First Vaccine For COVID-19

December 12th 2020

By Conor Killmurray

The Food and Drug Administration has issued the first emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in people 16 years old and older.

FDA Panel Recommends Emergency Use Authorization of Pfizer’s COVID-19 Vaccine

December 10th 2020

By Ryan McDonald

The FDA’s Vaccines and Related Biological Products Advisory Committee voted in favor of granting BNT162b2, the COVID-19 vaccine developed by Pfizer and BioNTech, emergency use authorization.

More Than Four Million Potential Years of Life Lost From Cancer Deaths in 2017

December 7th 2020

By Darlene Dobkowski, MA

Most of the potential years of life lost, a measure of the impact of cancer-related deaths especially in younger patients, were attributed to cancers such as colon, lung and breast.

How Cold Weather Affects Patients with Cancer

December 5th 2020

By Tampa Bay Radiation Oncology

Winter brings added challenges for patients with cancer. Here's what you need to know to take into consideration as the weather gets colder.

How Personalized Interventions Based on Patient Feedback Will Shape the Future of Geriatric Cancer Care

November 18th 2020

By Jessica Skarzynski

In order to create a better treatment landscape for geriatric patients with cancer, patients need to be involved in the process in order to shape personalized interventions.

Plinabulin-Neulasta Combo Significantly Prevents Chemotherapy-Induced Neutropenia, Compared to Standard of Care Alone

November 17th 2020

By Ryan McDonald

Topline results from the phase 3 PROTECTIVE-2 study demonstrated that plinabulin in combination with Neulasta (pegfilgrastim) significantly improved the prevention of chemotherapy-induced neutropenia, compared to the standard of care alone.

Why is Malnutrition Important to Monitor in Patients with Cancer?

November 16th 2020

By Jessica Skarzynski

Nutrition is a vital aspect for patients with cancer, and malnutrition is a concern that must be tracked through the cancer journey.

Antipsychotic Agent May Prevent Vomiting, Nausea in Children Receiving Chemotherapy

November 10th 2020

By Darlene Dobkowski, MA

A randomized, controlled trial comparing olanzapine with a standard antiemetic regimen resulted in more patients achieving no vomiting and no rescue medication during the acute, delayed and overall periods.

Picking Away at the Oral Side Effects of Cancer Treatment

November 5th 2020

By Ryan McDonald

In this episode of the “CURE Talks Cancer” podcast, we spoke with the dental director in the oral health program at the Rhode Island Department of Health about the oral health issues that can occur as a result of a patient’s cancer treatment.